These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11171783)

  • 1. Of phospholamban, mice, and humans with heart failure.
    Bristow M
    Circulation; 2001 Feb; 103(6):787-8. PubMed ID: 11171783
    [No Abstract]   [Full Text] [Related]  

  • 2. G-protein-coupled receptor function in heart failure.
    Prasad SV; Nienaber J; Rockman HA
    Cold Spring Harb Symp Quant Biol; 2002; 67():439-44. PubMed ID: 12858569
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice.
    Rockman HA; Koch WJ; Milano CA; Lefkowitz RJ
    J Mol Med (Berl); 1996 Sep; 74(9):489-95. PubMed ID: 8892053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation.
    Kuschel M; Karczewski P; Hempel P; Schlegel WP; Krause EG; Bartel S
    Am J Physiol; 1999 May; 276(5):H1625-33. PubMed ID: 10330247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the consequences of phosphorylation and hyperphosphorylation of ryanodine receptors in normal and failing heart?
    Bridge JH; Savio-Galimberti E
    Circ Res; 2008 May; 102(9):995-7. PubMed ID: 18467636
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.
    Koch WJ; Rockman HA; Samama P; Hamilton RA; Bond RA; Milano CA; Lefkowitz RJ
    Science; 1995 Jun; 268(5215):1350-3. PubMed ID: 7761854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insight into the role of enhanced adrenergic receptor-effector coupling in the heart.
    Feldman AM; McTiernan C
    Circulation; 1999 Aug; 100(6):579-82. PubMed ID: 10441092
    [No Abstract]   [Full Text] [Related]  

  • 9. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
    Schmitt JP; Kamisago M; Asahi M; Li GH; Ahmad F; Mende U; Kranias EG; MacLennan DH; Seidman JG; Seidman CE
    Science; 2003 Feb; 299(5611):1410-3. PubMed ID: 12610310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.
    Irie T; Sips PY; Kai S; Kida K; Ikeda K; Hirai S; Moazzami K; Jiramongkolchai P; Bloch DB; Doulias PT; Armoundas AA; Kaneki M; Ischiropoulos H; Kranias E; Bloch KD; Stamler JS; Ichinose F
    Circ Res; 2015 Oct; 117(9):793-803. PubMed ID: 26259881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic receptors in failing human myocardium.
    Brodde OE
    Basic Res Cardiol; 1996; 91 Suppl 2():35-40. PubMed ID: 8957542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity.
    Sande JB; Sjaastad I; Hoen IB; Bøkenes J; Tønnessen T; Holt E; Lunde PK; Christensen G
    Cardiovasc Res; 2002 Feb; 53(2):382-91. PubMed ID: 11827689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
    J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression.
    Cho MC; Rapacciuolo A; Koch WJ; Kobayashi Y; Jones LR; Rockman HA
    J Biol Chem; 1999 Aug; 274(32):22251-6. PubMed ID: 10428792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial overexpression of adrenergic receptors and receptor kinases.
    Koch WJ; Lefkowitz RJ; Milano CA; Akhter SA; Rockman HA
    Adv Pharmacol; 1998; 42():502-6. PubMed ID: 9327950
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice.
    Rockman HA; Choi DJ; Rahman NU; Akhter SA; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9954-9. PubMed ID: 8790438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for myocardial beta-adrenergic receptor desensitization in heart failure.
    Hammond HK
    Circulation; 1993 Feb; 87(2):652-4. PubMed ID: 8381061
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenylyl cyclase: a new target for heart failure therapeutics.
    Feldman AM
    Circulation; 2002 Apr; 105(16):1876-8. PubMed ID: 11997269
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality.
    Dash R; Kadambi V; Schmidt AG; Tepe NM; Biniakiewicz D; Gerst MJ; Canning AM; Abraham WT; Hoit BD; Liggett SB; Lorenz JN; Dorn GW; Kranias EG
    Circulation; 2001 Feb; 103(6):889-96. PubMed ID: 11171800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.